首页> 外文期刊>Transplant international : >Endoscopic retrograde cholangio‐pancreatography in the management of biliary complications after paediatric liver transplantation – a retrospective study
【24h】

Endoscopic retrograde cholangio‐pancreatography in the management of biliary complications after paediatric liver transplantation – a retrospective study

机译:内镜下逆行胆管胰蛋白酶在儿科肝移植后胆道并发症管理 - 回顾性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Summary The published paediatric experience with endoscopic retrograde cholangio‐pancreatography ( ERCP ) in the diagnosis and management of biliary complications following liver transplantation ( LT ) is limited. We describe our experience with ERCP in the management of children following LT who presented with biliary complications, over a 20‐year period (1995–2014). The retrospectively reviewed data are summarized descriptively. Of 94 children (47 boys) who received 102 liver transplants at our centre, seven children (five boys, two girls) underwent ERCP after liver transplantation. In total, 25 ERCP procedures were carried out in these patients. The median age at liver transplantation was 10.7 (3.9–16.2) years. The median interval between LT and the first ERCP was 28 days (12 days–6.8 years). All patients were on standard calcineurin‐inhibitor‐based immunosuppression regimens. Six of the seven patients underwent ERCP on more than one occasion [median number of ERCP sessions per patient‐ 4, (1–6)]. Seventeen procedures were carried out under conscious sedation, remaining eight under general anaesthesia. Sedation was achieved employing a standard regimen (Midazolam 5 mg with Pethidine 50 mg) and occasionally Fentanyl. ERCP is an effective and safe intervention from both diagnostic and therapeutic point of view, in the management of post‐ LT biliary complications in children.
机译:发明内容肝脏移植(LT)后胆道并发症的胆囊并发症的胆管胰蛋白酶(ERCP)的出版儿科经验是有限的。在20年期(1995-2014)中,我们在患有胆道并发症的LT的儿童管理中描述了我们在培育者的管理中描述了我们的经验。回顾性地审查的数据被概述了。在94名儿童(47名男孩)中,他们在我们的中心接受了102名肝脏移植,七个孩子(五个男孩,两个女孩)肝移植后接受了ERCP。共有25例ERCP程序在这些患者中进行。肝移植的中位年龄为10.7(3.9-16.2)年。 LT和第一个ERCP之间的中位间隔为28天(12天 - 6.8岁)。所有患者均采用标准煅烧酶抑制剂的免疫抑制方案。七名患者中有六个接受了ERCP的一个以上的一次[每位患者的ERCP会话的中位数 - 4,(1-6)]。在有意识的镇静下进行了十七个程序,在全身麻醉下剩下八个。使用标准方案(咪达唑仑5mg用Pethidine 50mg)和偶尔芬太尼实现镇静。 ERCP是诊断和治疗的有效和安全的介入,在儿童的胆量并发症的管理中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号